Highlights Sapporo Clinical Laboratory Inc.

Equities

9776

JP3321100004

Delayed Japan Exchange Other stock markets 02:11:47 18/07/2024 BST			5-day change	1st Jan Change
1,012 ^JPY	+0.40%		+0.30%	+1.10%

03-27	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.	CI
03-26	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.	CI

Highlights

Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.	03-27	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.	03-25	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.	02-26	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	02-25	CI
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.	31/05/22	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.	30/05/22	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.	30/05/22	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	29/05/22	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.	01/03/22	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.	28/02/22	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.	28/02/22	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	27/02/22	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.	22/06/21	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.	21/06/21	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.	21/06/21	CI
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	20/06/21	CI
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.	27/06/18	CI
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.	26/06/18	CI
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.	26/06/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sapporo Clinical Laboratory Inc.

Equities

9776

JP3321100004

Highlights

Filters